Protocol Number: TROV -053 
Official Title:  A Phase 2 Study of Onvansertib  (PCM -075) in Combination with Abiraterone and 
Prednisone in Patients with Metastatic Castration -Resistant Prostate Cancer  
Study ID: [REMOVED]  
Document Date: 16 Nov 2020  